Group 3 NCR+ Innate Lymphoid Cells accumulate in human lung cancer

Guido Ferlazzo,Mariacristina Mingari,Paolo Carrega
DOI: https://doi.org/10.4049/jimmunol.196.supp.142.18
2016-05-01
The Journal of Immunology
Abstract:Abstract Tertiary lymphoid structures (TLS) are a common finding in non-small-cell lung (NSCL) cancers and are predictors of favorable clinical outcome. Here, we show that NCR+ Innate-Lymphoid-Cells (ILC)3s are present in the lymphoid infiltrate of human NSCL carcinomas and are mainly localized at the edge of tumor-associated TLS. This intra-tumoral lymphocyte subset is endowed with lymphoid tissue-inducing properties and, upon activation, produces IL-22, TNF-α, IL-8, IL-2 and activates endothelial cells. Tumor-NCR+ ILC3 may interact with both lung tumor cells and tumor-associated fibroblasts, resulting in the release of cytokines primarily upon engagement of the NKp44 activating receptor. In patients, NCR+ ILC3s are present in significantly higher amounts in stage I/II NSCL cancers than in more advanced tumor stages. Our results indicate that NCR+ ILC3s are associated with human NSCL cancer and may contribute to the formation of protective tumor-associated TLS.
immunology
What problem does this paper attempt to address?